Background-In idiopathic pulmonary arterial hypertension (IPAH), increased right ventricular (RV) power is required to maintain cardiac output. For this, RV O 2 consumption (MVO 2 ) must increase by augmentation of O 2 supply and/or improvement of mechanical efficiency-ratio of power output to MVO 2 . In IPAH with overt RV failure, however, there is evidence that O 2 supply (perfusion) reserve is reduced, leaving only increase in either O 2 extraction or mechanical efficiency as compensatory mechanisms. We related RV mechanical efficiency to clinical and hemodynamic parameters of RV function in patients with IPAH and associated it with glucose metabolism. Methods and Results-The patients included were in New York Heart Association (NYHA) class II (nϭ8) and class III (nϭ8). They underwent right heart catheterization, MRI, and H 2 15 O-, 15 O 2 -, C 15 O-, and 18 FDG-PET. RV power and O 2 supply were similar in both groups (NYHA class II versus class III: 0.54Ϯ0.14 versus 0.47Ϯ0.12 J/s and 0.109Ϯ0.022 versus 0.128Ϯ0.026 mL O 2 /min per gram, respectively). RV O 2 extraction was near-significantly lower in NYHA class II compared with NYHA class III (63Ϯ17% versus 75Ϯ16%, respectively, Pϭ0.10). As a result, MVO 2 was significantly lower (0.066Ϯ0.012 versus 0.092Ϯ0.010 mL O 2 /min per gram, respectively, Pϭ0.006). RV efficiency was reduced in NYHA class III (13.9Ϯ3.8%) compared with NYHA class II (27.8Ϯ7.6%, Pϭ0.001). Septal bowing, measured by MRI, correlated with RV efficiency (rϭϪ0.59, Pϭ0.020). No relation was found between RV efficiency and glucose uptake rate. RV mechanical efficiency and ejection fraction were closely related (rϭ0.81, PϽ0.001). Conclusions-RV failure in IPAH was associated with reduced mechanical efficiency that was partially explained by RV mechanical dysfunction but not by a metabolic shift. (Circ Heart Fail. 2011;4:700-706.)
the spatial resolution of state-of-the-art PET scanners and 15 O 2 and C 15 O tracers. 11 We also measured RV perfusion, using H 2 15 O-PET next to OEF to calculate RV MVO 2 . 12 The purposes of this study were to (1) determine the relationship between RV power output and MVO 2 in IPAH patients and (2) relate RV mechanical efficiency to RV function, using both clinical and functional assessments in IPAH patients. We also determined whether mechanical RV dysfunction and RV glucose uptake rate related to the RV efficiency that was found.
Methods Patients
Twenty-six patients with IPAH were eligible for study. Five patients refused to participate and 5 other patients gave consent but were subsequently withdrawn because of emergence of severe clinical condition (nϭ2; hemoptysis and endocarditis) or because of unsuccessful cannula placement in the radial or brachial artery (nϭ3). In total, 16 patients were included, of which 15 patients were on optimal treatment and diagnosed with IPAH for a median time of 3 years, ranging from 2 months to 7 years. All patients continued receiving treatment (Table 1) . One patient was newly diagnosed with severe IPAH and included right before start of drug treatment. Exclusion criteria were known history of coronary artery disease or diabetes mellitus, atrial fibrillation, and anemia (hemoglobin Ͻ0.13 g/mL). Assessment of the World Health Organization's 1998 adapted New York Heart Association classification was performed before study participation by the clinicians responsible for the patient (A.V.N. and A.B.). The protocol was approved by the Medical Ethics Review Committee of VU University Medical Center. Each patient gave written informed consent before study. Y.Y.W. and G.R. analyzed the images blinded for patient's clinical state.
Study Design
All patients underwent right heart catheterization (RHC), cardiac MRI (cMRI), and PET that consisted of 3 consecutive scans using H 2 15 O, 15 O 2 , and C 15 O to measure myocardial perfusion or blood flow (MBF), OEF and MVO 2 and fractional blood volume, respectively ( Figure 1 ). 15 O-PET scans were performed 2 hours after a light breakfast. One day after the 15 O-PET scans, an 18 FDG scan was performed to quantify myocardial glucose uptake rate (online-only Data Supplement Figure I, A and B). When possible, RHC, cMRI, and PET studies were performed within 1 week of each other. In 3 subjects, for logistical or personal reasons, the interval between RHC and PET was 20 -55 days and between cMRI and PET, 20 -36 days. Because these patients had stable IPAH under drug treatment, that is, less than 10% change in 6-minute walk distance over 6 months before inclusion (5Ϯ3%) and no change in medical therapy or NYHA class, the interval was considered acceptable.
PET Imaging Protocol
Patients received a cannula in the radial or brachial artery for blood sampling.
Data Acquisition
The protocol for cardiac H 2 15 O and C 15 O scans has been described previously. 12 Briefly, scans were performed in 2D acquisition mode, using an ECAT EXACT HRϩ scanner (Siemens/CTI, Knoxville, TN). After a transmission scan used to correct all subsequent scans for tissue attenuation, subjects underwent 3 consecutive scans, as shown in Figure 1 . First, a dynamic emission scan (10 minutes, 40 frames with progressive increase in duration) was started simultaneously with injection of 1100 MBq H 2 15 O. A second identical emission scan was started at the same time as a bolus inhalation 7 GBq 15 O 2 . During the 15 O 2 scan, 5 arterial blood samples were obtained to measure recirculating H 2 15 O concentration. 11 An additional arterial sample was drawn to determine arterial O 2 content. Finally, a 6-minute static emission scan was acquired, starting 1 minute after the end of bolus inhalation of 4 GBq C 15 O gas to allow imaging of ventricular blood volumes. Approximately 20% of the administered radioactivity during 15 O 2 and C 15 O inhalation is taken up by the blood. 13 During all scans, systemic blood pressure and peripheral saturation were registered at set intervals. Heart rate and ECG were monitored continuously.
Image Processing and Data Analysis
All emission data were reconstructed as previously described. 12 The anatomic tissue fraction images, generated by subtracting the C 15 O blood pool image from transmission image, 14 were resliced into short-axis images according to anatomic axes of the LV. The same reslicing parameters were applied to both dynamic H 2 15 O and 15 O 2 images. Using anatomic tissue fraction images, RV wall regions of Values are meanϮSD. P values were tested using t test. interest were defined on basal, distal, and apical planes ( Figure 2 ). These regions of interest were projected onto dynamic H 2 15 O and 15 O 2 images to generate time-activity curves. Next, volume weighted averages of basal, distal, and apical time-activity curves were averaged. MBF was determined from these average time-activity curves, using the standard single tissue compartment model. 15 OEF was determined from 15 O 2 scan using dynamic implementation 11 of a previously described model, 14 reusing MBF, perfusable tissue fraction, arterial blood volume, and RV spill-over as determined from the H 2 15 O scan and applying a correction for spill-over from activity in the pulmonary gas volume as described previously. 16 15 O 2 input function was based on volume of interest drawn in ascending aorta and corrected for contribution of recirculating water measured in the arterial blood samples.
Hemodynamic and Oxidative Calculations
A brief description is provided for both RHC and cMRI in the online-only Data Supplement.
RV ejection fraction (EF) was derived as the ratio of stroke volume (SV, assessed from aortic flow) to RV end-diastolic volume. RV postsystolic isovolumic period, which is the time between pulmonary valve closure and tricuspid valve opening, was determined in the 2-chamber view described previously and corrected for RR time. 17 The interventricular septum plays an important role in RV power generation in PAH. Therefore, total septal mass, determined by LV mass minus LV free wall mass, was divided into a right and left septal mass, assuming that the right and left parts of the septal masses are proportional to their free wall counterparts. The right septal part was included to the RV wall mass in the following calculations.
RV Power
Combining hemodynamic data from both RHC and cMRI, the power (J/s) of the RV was calculated as
where HR is heart rate in beats per minute and mPAP is in mm Hg; SV, in milliliters, was assessed from the difference between LV end-diastolic volume and end-systolic volume, which was found to be equally accurate as the forward aortic flow for SV assessment in IPAH. 18 The factor 2.22 ⅐ 10 Ϫ6 converts mm Hg ⅐ L/min to J/s. Only mean power output is used in the present study. Saouti et al showed total power equals 1.23 times mean power 19 and thus does not affect the results qualitatively.
RV Oxygen Consumption and Supply
Regional MVO 2 (in mL/min per gram of cardiac tissue) was calculated for the RV as follows 14 :
(2)
where CaO 2 is arterial O 2 content (mL O 2 /mL blood). 14 Mechanical efficiency was calculated from the ratio of RV power output (Eq 1) and MVO 2 (Eq 2). As MVO 2 in Equation 2 is calculated per gram, RV mass is included here for calculation of MVO 2 by whole RV. To convert RV MVO 2 to units of metabolic power (J/s), it was multiplied by the caloric equivalent of O 2 : 1 mL of O 2 /min corresponds to about 0.34 J/s, assuming that RV oxidizes free fatty acid and glucose equally:
Statistical Analysis
All results are expressed as meanϮSD. The 2 groups (ie, NYHA classes II and III) were compared using t tests; the nonparametric Mann-Whitney U test was used where indicated. Pearson correlation was performed where necessary. All statistics were performed using Prism 5 for Windows (GraphPad Software, San Diego, CA). PϽ0.05 was considered significant.
Results
Patient characteristics and hemodynamics are summarized in Table 1 ; some parameters are also shown in Figure 3 . In accordance with severity of IPAH, NYHA class III patients had lower SV and cardiac output (CO) ( Figure 3A ), despite higher heart rate as compared with NYHA class II. Mean PAP was near-significantly higher in NYHA class III as compared with class II ( Figure 3B ; Pϭ0.083, Mann-Whitney U test). PVR was increased in NYHA class III, whereas RV mass was similar in the 2 groups. RVEF and SvO 2 were lower in NYHA class III. Six-minute walk distance was not significantly lower in the severely ill. PET-derived parameters for the RV per cardiac mass are shown in Table 2 . Both MBF (corrected for RV mass, Figure  3C ) and OEF ( Figure 3D) were not significantly higher in the NYHA class III (MBF: Pϭ0.088, t test; OEF: Pϭ0.105, Mann-Whitney U test). There was, however, a significantly higher MVO 2 per gram ( Table 2 ). In contrast, RV O 2 supply per gram RV was similar in NYHA class II and class III patients ( Table 2) . For total RV, MVO 2 was also higher in the severely ill ( Figure 3F ), whereas RV power was not significantly lower ( Figure 3E ). This led to a significant reduction of RV efficiency by Ϸ50% in the NYHA class III patients compared with the NYHA class II patient group ( Figure 3G) .
A tight relationship was found between the mechanical efficiency and RVEF, a hemodynamic index of systolic RV function parameter (Figure 4, rϭϪ0.81, PϽ0.001 ). There was also a high correlation between RV efficiency and SvO 2 (rϭ0.76, PϽ0.001).
In search for an underlying mechanical cause for the reduced efficiency, postsystolic isovolumic period was plotted against the RV efficiency, showing a negative correlation (rϭϪ0.594, Pϭ0.020, Figure 5 ). No correlation was found between the RV myocardial glucose uptake rate and RV efficiency (rϭϪ0.38; Pϭ0.18, online-only Data Supplement Figure I, C) .
Discussion
In the present study, we demonstrate that RV mechanical efficiency is lower in NYHA class III than in NYHA class II patients ( Figure 3G ), indicating a decrease with progression of IPAH. In addition, the strong relation between RVEF and mechanical efficiency (Figure 4 ) stresses the fact that decreasing mechanical efficiency is a characteristic for deterioration of RV function in IPAH. The reduced efficiency in NYHA class III patients is not related to RV power output, because this was similar between the 2 groups ( Figure 3E ), but NYHA class III patients had higher MVO 2 of both total RV ( Figure 3F ) and per unit RV mass ( Table 2) as compared with NYHA class II.
To the best of our knowledge, there are no previous data on human OEF and perfusion of the normal RV to compare with our patient data. Based on canine studies, normal RV OEF has been estimated as 45-50%, 20, 21 indicating that the RV has a substantially higher O 2 extraction reserve than the left heart (OEF values are 60 -80% in healthy men). 4, 5 Additionally, Hart et al 21 demonstrated that during heavy exercise, RV O 2 utilization increases initially by maximizing OEF before coronary reserve is mobilized. Interestingly, we found a mean RV OEF of 69Ϯ17% in our IPAH patients ( Figure 3D ), approximating that of normal LV. Our data suggests that in analogy with the normal (canine) RV during strenuous exercise, the pressure-overloaded RV in IPAH already has a reduced O 2 extraction reserve at rest, and resting O 2 demand becomes predominantly dependent on perfusion. We found similar MBF in the hypertrophied RV between mild and severe IPAH. We therefore hypothesize that the dysfunctional RV is unable to increase its perfusion in severe PAH, and thus O 2 supply cannot increase to meet a higher O 2 demand (eg, during physical exercise). RV ischemia is then the result, which is in accordance with the observation by Gomez et al, who demonstrated stress-induced RV wall ischemia in IPAH patients with severe heart failure. 1 The high RV OEF that we found may also increase the risk to develop hypoxia in the hypertrophied RV cardiomyocytes.
RV power in the NYHA class III group was similar to NYHA class II ( Figure 3E ), despite lower SV and CO (Table  1 and Figure 3A ), but we must take into account that RV power is significantly higher compared with the normal RV (online-only Data Supplement Figure II) . Previous studies also demonstrated that patients with advanced IPAH had significantly reduced CO but similar mPAP as compared with mild IPAH. [22] [23] [24] The RV power that can be calculated from the data provided in these studies [22] [23] [24] is also not significantly lower in the patients with progressive IPAH, which is in agreement with our data. It follows from the lower CO and unchanged mPAP that PVR is higher in the NYHA class III patients (Table 2) . Apparently, RV power output cannot be increased in advanced IPAH to maintain CO and SV, which is a sign of RV failure. This is further supported by the tight relationship between RVEF and mechanical efficiency (Figure 4 ), which has also been shown in patients with ischemic LV heart disease. 6 Reduced SvO 2 is a strong prognostic determinant in IPAH, as it is associated with a decreased cardiac output in the severely ill. It is noticeable that RV efficiency independently correlates well with SvO 2 , emphasizing once more that mechanical efficiency is a strong indicator for RV function.
Potential Underlying Mechanisms of Mechanical Inefficiency at the Mechanical and/or Cardiomyocyte Level
Mechanical dysfunction can be due to tricuspid regurgitation, septal bowing, 25 asynchronous activation, 25 and/or diastolic dysfunction. 26 Power output loss caused by tricuspid regurgitation, however, was small and did not influence the mechanical efficiency in our present study (online-only Data Supplement Table I ). In contrast, we did find a weak but significant inverse relation between prolonged postsystolic isovolumic period and reduced RV efficiency ( Figure 5 ). Based on recent insight, 17 this prolonged period is related to the postsystolic RV isovolumetric contraction period rather than a prolonged diastolic relaxation time, indicating the presence of abnormal increased RV wall tension in these patients. 25 This prolonged period is visible on echocardiography or cMRI as leftward septal bowing after pulmonary valve closure, increasing RV MVO 2 without ejection of blood. The low correlation coefficient found between this period and RV efficiency, however, suggests that the reduced efficiency cannot be explained by this prolonged isovolumic contraction period alone. Prostacyclin was shown to improve the right arterioventricular coupling through reduction of arterial elastance. 27 This treatment was more common in the NYHA class III group (Table 1) . Nevertheless, it did not prevent the reduced RV efficiency in our patient population. Furthermore, it is possible that myocardial fibrosis contributes to a reduced mechanical efficiency. Blyth et al found that patients with a lower RVEF had more myocardial fibrosis than patients with a preserved RVEF. 28 Additional causes for reduced efficiency must be sought at the cardiomyocyte level in advanced RV failure. Unfortunately, it is not possible to obtain RV cardiac tissue in our study population for histological analysis of morphological changes or capillary density. Preclinical pulmonary hypertension (PH) studies, however, show that RV cardiomyocytes are enlarged with reduced capillary density. 29, 30 The oxygen diffusion distance is increased as the result of these changes, which may be an underlying cause for reduction in efficiency. Indeed, we recently showed a similar reduction in mechanical efficiency in the isolated, hypertrophied RV papillary muscle obtained from an experimental PH model. 31 Chronic heart failure takes place with a metabolic shift from free fatty acids to glucose oxidation. 3, 4, 8 This shift was demonstrated also in the hypertrophied RV in experimental and clinical PAH studies. [32] [33] [34] In theory, the efficiency should increase because glucose oxidation yields more energy than fat oxidation per mole of oxygen. However, in heart failure, the shift to glucose oxidation appears to concur with the presence of reduced mechanical efficiency, suggesting that the glucose shift is a secondary phenomenon to the diminished efficiency. We also measured the glucose metabolism in our patients and found that the RV glucose uptake rate was similar in NYHA class II and NYHA class III patients (Pϭ0.18; online-only Data Supplement Figure I, C) . The increased MVO 2 to power output in severe IPAH suggests inefficient O 2 utilization by the failing RV as the result of cellular processes in which O 2 is used for processes other than ATP production for contraction, for example, ion pumps, protein turnover, mitochondrial uncoupling, or oxygen radical formation. 2, 3, Indeed, local administration of XO inhibitor, NO-synthase inhibitor or vitamin C (a reactive oxygen species scavenger) have been shown to ameliorate the low LV efficiency in cardiomyopathy patients; 2,7,39 as well, it was reported to attenuate RV failure in a PH rat model. 40 Future studies on the isolated RV papillary muscle of PH rats are warranted to test whether these substances also improve the reduced RV efficiency found in PH.
Our data indicate that clinical judgment, for example, NYHA class-a well-known prognostic determinant for survival in PAH-is a reflection of the RV mechanical inefficiency. 23 We hypothesize that there is not only a mere association between NYHA class and mechanical efficiency but that RV inefficiency is an underlying factor causing clinical deterioration and that it plays a central role in RV failure in IPAH.
Limitations
We acknowledge that the present study lacks a control group. Unfortunately, the normal RV wall is too thin for accurate measurements of MBF and OEF, given the spatial resolution of current PET scanners. Nevertheless, we were able to include patients with sufficiently different disease severity to discover the significant correlation between RV efficiency and RVEF. Ideally, all measurements required for calculation of mechanical efficiency should be acquired simultaneously. This was not possible because of the variety of measurement modalities used. However, only clinically stable IPAH patients participated in this study, and most measurements were performed within 1 week. We have chosen to include part of the septum in the RV myocardial mass. To date, it is not clear how much it contributes to RV pumping and O 2 consumption in IPAH. We performed calculations of RV efficiency also by taking either the full septum into account or only the RV free wall and found qualitatively similar results (online-only Data Supplement Figure III) . Finally, it would be interesting to compare the RV mechanical efficiency between different PAH subgroups. Differences in RV mechanical efficiency may be an underlying factor to explain the differences found in the hemodynamics and prognosis between IPAH patients and patients with PAH secondary to scleroderma or Eisenmenger syndrome.
Conclusion
RV mechanical efficiency is reduced in severe IPAH compared with milder stages of the disease process and is only partially explained by RV mechanical dysfunction, but not by a metabolic shift to glucose oxidation. The reduction in mechanical efficiency is strongly correlated with RVEF, implying that the increased O 2 use relative to power output is a feature of RV failure.
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